Concepts (36)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Mastectomy, Segmental | 2 | 2026 | 49 | 1.140 |
Why?
|
| Breast Neoplasms | 3 | 2026 | 1211 | 1.110 |
Why?
|
| Aromatase Inhibitors | 1 | 2026 | 25 | 0.950 |
Why?
|
| Neoplasms, Multiple Primary | 1 | 2026 | 33 | 0.950 |
Why?
|
| Antineoplastic Agents, Hormonal | 1 | 2026 | 36 | 0.940 |
Why?
|
| Carcinoma, Intraductal, Noninfiltrating | 1 | 2026 | 27 | 0.940 |
Why?
|
| Neoadjuvant Therapy | 1 | 2026 | 97 | 0.900 |
Why?
|
| Neoplasm Recurrence, Local | 2 | 2026 | 358 | 0.850 |
Why?
|
| Surgeons | 1 | 2026 | 182 | 0.780 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2026 | 457 | 0.730 |
Why?
|
| Practice Patterns, Physicians' | 1 | 2026 | 708 | 0.650 |
Why?
|
| Prognosis | 3 | 2026 | 1769 | 0.380 |
Why?
|
| Follow-Up Studies | 2 | 2026 | 2478 | 0.320 |
Why?
|
| Prospective Studies | 2 | 2026 | 3315 | 0.280 |
Why?
|
| Tamoxifen | 1 | 2026 | 42 | 0.240 |
Why?
|
| Chemotherapy, Adjuvant | 1 | 2026 | 91 | 0.230 |
Why?
|
| Receptors, Estrogen | 1 | 2026 | 130 | 0.230 |
Why?
|
| Combined Modality Therapy | 1 | 2026 | 374 | 0.220 |
Why?
|
| Nomograms | 1 | 2025 | 19 | 0.220 |
Why?
|
| Retrospective Studies | 3 | 2026 | 6726 | 0.220 |
Why?
|
| Hemangiosarcoma | 1 | 2025 | 25 | 0.220 |
Why?
|
| Survival Rate | 1 | 2026 | 859 | 0.200 |
Why?
|
| Aged | 3 | 2026 | 14648 | 0.170 |
Why?
|
| Middle Aged | 4 | 2026 | 17898 | 0.170 |
Why?
|
| Mammaplasty | 1 | 2022 | 47 | 0.170 |
Why?
|
| Triple Negative Breast Neoplasms | 1 | 2022 | 73 | 0.170 |
Why?
|
| Adult | 3 | 2026 | 17116 | 0.160 |
Why?
|
| Female | 4 | 2026 | 33350 | 0.130 |
Why?
|
| Humans | 4 | 2026 | 64238 | 0.090 |
Why?
|
| SEER Program | 1 | 2025 | 75 | 0.050 |
Why?
|
| Mastectomy | 1 | 2022 | 55 | 0.040 |
Why?
|
| Incidence | 1 | 2025 | 1383 | 0.040 |
Why?
|
| Prevalence | 1 | 2025 | 1407 | 0.040 |
Why?
|
| Aged, 80 and over | 1 | 2025 | 5520 | 0.030 |
Why?
|
| United States | 1 | 2025 | 7923 | 0.020 |
Why?
|
| Male | 1 | 2025 | 30294 | 0.010 |
Why?
|